AI assistant
Compass Therapeutics, Inc. — Director's Dealing 2020
Jun 29, 2020
32588_dirs_2020-06-29_5fe085cd-1a15-45f8-8150-1633896f44df.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Compass Therapeutics, Inc. (NONE)
CIK: 0001738021
Period of Report: 2020-06-17
Reporting Person: ANDERSON ERRIK (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3244729 | Direct |
| Common Stock | 1661899 | Indirect |
| Common Stock | 383642 | Indirect |
Footnotes
F1: These shares are held directly by GTP AW Fund I, LLC. Growth Technology Parters AW, LLC is the general partner of GTP AW Fund I, LLC. The Reporting Person is a managing partner of Growth Technology Partners AW, LLC. The Reporting Person disclaims beneficial ownership of the shares held by GTP AW Fund I, LLC, except to the extent of any actual interest.
F2: These shares are held directly by GTP AW Fund II, LLC. Growth Technology Parters AW II, LLC is the general partner of GTP AW Fund II, LLC. The Reporting Person is a managing partner of Growth Technology Partners AW II, LLC. The Reporting Person disclaims beneficial ownership of the shares held by GTP AW Fund II, LLC, except to the extent of any actual interest.